Is a complete FBIO research report available?

No complete published report is available for Fortress Biotech, Inc. (FBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Fortress Biotech, Inc. (FBIO)

NASDAQ: FBIO · USD

$1.95

+0.02 (+1.0%)· Recorded snapshot

Market cap	65M
Revenue (ttm)	68.5M
Net income (ttm)	103.4M
EPS (ttm)	$3.25
Shares out	33.4M
P/E (trailing)	0.6x
P/E (forward)	2.5x
Volume	120,188
Beta	1.25

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Metric	Value
Amount currency	USD
CIK code	0001429260
Company name	Fortress Biotech, Inc.
Country	United States
Country code	US
CUSIP number	34960Q307
Earnings date	2026-11-13
Earnings time	bmo
Employees	78
Employees change	-23
Employees growth	-22.77%
Enterprise value	$-78.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US34960Q3074
Last 10-K release date	2026-03-31
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2023-10-10
Last stock split type	Reverse
Market cap	$65M
Market cap category	Micro-Cap
Next earnings date	2026-11-13
Options	Yes
Price	$1.95
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	FBIO
U.S. state	Florida
Website	https://www.fortressbiotech.com

Metric

Value

Amount currency

USD

CIK code

0001429260

Company name

Fortress Biotech, Inc.

Country

United States

Country code

CUSIP number

34960Q307

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

-23

Employees growth

-22.77%

Enterprise value

$-78.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US34960Q3074

Last 10-K release date

2026-03-31

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2023-10-10

Last stock split type

Reverse

Market cap

$65M

Market cap category

Micro-Cap

Next earnings date

2026-11-13

Options

Yes

Price

$1.95

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

FBIO

U.S. state

Florida

Website

https://www.fortressbiotech.com

Metric	Value
Earnings yield	166.64%
FCF / EV yield	-159.51%
FCF yield	195.5%
Forward P/E	2.53x
Forward P/S	1.46x
Graham number	18.98049
Graham upside	883.45%
P/(FCF - SBC) ratio	0.56x
P/(OCF - SBC) ratio	0.56x
P/B ratio	0.39x
P/E ratio	0.6x
P/FCF ratio	0.51x
P/OCF ratio	0.51x
P/S ratio	0.94x
Price / tangible book value	0.46x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

166.64%

FCF / EV yield

-159.51%

FCF yield

195.5%

Forward P/E

2.53x

Forward P/S

1.46x

Graham number

18.98049

Graham upside

883.45%

P/(FCF - SBC) ratio

0.56x

P/(OCF - SBC) ratio

0.56x

P/B ratio

0.39x

P/E ratio

0.6x

P/FCF ratio

0.51x

P/OCF ratio

0.51x

P/S ratio

0.94x

Price / tangible book value

0.46x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-43.2%
EBITDA margin	-36.48%
Effective tax rate	3.31%
FCF margin	183.8%
Gross margin	63.28%
Operating margin	-43.2%
Pretax margin	213.28%
Profit margin	163.32%
Profit per employee	$1.3M
Revenue per employee	$877,769
ROA	-7.76%
ROA (5Y)	-34.74%
ROCE	-11.61%
ROE	115.99%
ROIC	-45.52%
SBC / revenue	15.03%
Tax / revenue	7.06%

Metric

Value

EBIT margin

-43.2%

EBITDA margin

-36.48%

Effective tax rate

3.31%

FCF margin

183.8%

Gross margin

63.28%

Operating margin

-43.2%

Pretax margin

213.28%

Profit margin

163.32%

Profit per employee

$1.3M

Revenue per employee

$877,769

ROA

-7.76%

ROA (5Y)

-34.74%

ROCE

-11.61%

ROE

115.99%

ROIC

-45.52%

SBC / revenue

15.03%

Tax / revenue

7.06%

Metric	Value
EPS growth years	3
Gross profit growth	362.12%
Gross profit growth (Q)	251.55%
Net income growth years	3
Revenue growth	15.46%
Revenue growth (Q)	14.04%
Revenue growth (QoQ)	16.71%
Revenue growth 10Y	35.62%
Revenue growth 3Y	2.95%
Revenue growth 5Y	5.39%
Revenue growth quarters	6
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

362.12%

Gross profit growth (Q)

251.55%

Net income growth years

Revenue growth

15.46%

Revenue growth (Q)

14.04%

Revenue growth (QoQ)

16.71%

Revenue growth 10Y

35.62%

Revenue growth 3Y

2.95%

Revenue growth 5Y

5.39%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-79,000
Depreciation and amortization	$4.6M
EBIT	$-29.6M
EBITDA	$-25M
EPS	$3.25
FCF per share	$3.77
Financing cash flow	$-6.5M
Free cash flow	$125.8M
Free cash flow minus SBC	$115.6M
Gross profit	$43.3M
Income taxes	$4.8M
Investing cash flow	$2.8M
Net borrowing	$-75,000
Net cash flow	$122.2M
Net income	$103.4M
Operating cash flow minus SBC	$115.6M
Operating income	$-29.6M
Revenue	$68.5M
Stock-based compensation	$10.3M

Metric

Value

Capital expenditures

$-79,000

Depreciation and amortization

$4.6M

EBIT

$-29.6M

EBITDA

$-25M

EPS

$3.25

FCF per share

$3.77

Financing cash flow

$-6.5M

Free cash flow

$125.8M

Free cash flow minus SBC

$115.6M

Gross profit

$43.3M

Income taxes

$4.8M

Investing cash flow

$2.8M

Net borrowing

$-75,000

Net cash flow

$122.2M

Net income

$103.4M

Operating cash flow minus SBC

$115.6M

Operating income

$-29.6M

Revenue

$68.5M

Stock-based compensation

$10.3M

Metric	Value
Altman Z-Score	-1.68
Book value per share	$4.93
Debt / equity	0.26
Debt / FCF	0.42
Interest coverage	-3.07
Long-term assets	$71.2M
Long-term liabilities	$48.6M
Net cash (debt)	$143.3M
Net cash / market cap	222.57%
Net cash growth	2,672.6%
Net debt / equity	-0.7
Net debt / FCF	-1.14
Piotroski F-Score	6
Property, plant and equipment	$13.8M
Shareholders' equity	$206.1M
Tangible book value	$138.6M
Tangible book value per share	$4.16
Total assets	$316.7M
Total cash	$196.6M
Total debt	$53.3M
Total liabilities	$110.6M
WACC	13.99%

Metric

Value

Altman Z-Score

-1.68

Book value per share

$4.93

Debt / equity

0.26

Debt / FCF

0.42

Interest coverage

-3.07

Long-term assets

$71.2M

Long-term liabilities

$48.6M

Net cash (debt)

$143.3M

Net cash / market cap

222.57%

Net cash growth

2,672.6%

Net debt / equity

-0.7

Net debt / FCF

-1.14

Piotroski F-Score

Property, plant and equipment

$13.8M

Shareholders' equity

$206.1M

Tangible book value

$138.6M

Tangible book value per share

$4.16

Total assets

$316.7M

Total cash

$196.6M

Total debt

$53.3M

Total liabilities

$110.6M

WACC

13.99%

Metric	Value
Asset turnover	0.29
Current assets	$245.5M
Current liabilities	$62M
Current ratio	3.96
Inventory turnover	2.39
Net working capital	$-5.8M
Quick ratio	3.76
Working capital	$183.5M
Working capital turnover	0.58

Metric

Value

Asset turnover

0.29

Current assets

$245.5M

Current liabilities

$62M

Current ratio

3.96

Inventory turnover

2.39

Net working capital

$-5.8M

Quick ratio

3.76

Working capital

$183.5M

Working capital turnover

0.58

Metric	Value
Buyback yield / dilution	-25.98%
Dividend yield	0%

Metric

Value

Buyback yield / dilution

-25.98%

Dividend yield

Metric	Value
10Y price change	-94.64%
10Y return CAGR	-25.37%
10Y total return	-94.64%
150-day SMA	$2.63
1D price change	1.04%
1M price change	-14.25%
1M total return	-14.25%
1W price change	0.77%
1W total return	0.77%
1Y price change	-23.93%
1Y return CAGR	-23.94%
1Y total return	-23.93%
20-day SMA	$1.98
200-day SMA	$2.80
3M price change	-40.21%
3M total return	-40.21%
3Y price change	9.83%
3Y return CAGR	3.17%
3Y total return	9.83%
50-day SMA	$2.34
50-day SMA vs 200-day SMA	50under200
52-week high	$4.53
52-week high date	2026-01-09
52-week low	$1.83
52-week low date	2026-10-19
5Y price change	-95.99%
5Y return CAGR	-47.45%
5Y total return	-95.99%
6M price change	-13.88%
6M total return	-13.88%
All-time high	$190.50
All-time high date	2013-04-23
All-time low	$1.24
All-time low date	2023-11-10
Average true range (ATR)	$0.09
Average volume	244.7K
Beta (1Y)	0.53
Beta (2Y)	0.71
Beta (5Y)	1.25
Change from 52-week high	-56.95%
Change from 52-week low	6.56%
Change from all-time high	-98.97%
Change from all-time low	57.66%
Change from open	0.52%
Day's gap	0.52%
Dollar volume	$234,367
High price	$1.97
Low price	$1.94
Monthly RSI	39.29
Open price	$1.94
Position in 52-week range	42.86%
Premarket change	0.52%
Premarket close	$1.93
Premarket price	$1.94
Premarket volume	113
Previous close	$1.93
Price vs 150-day SMA	-25.64%
Price vs 20-day SMA	-1.41%
Price vs 200-day SMA	-30.28%
Price vs 50-day SMA	-16.49%
Relative volume	0.49
RSI	39.59
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	-0.34
Sortino ratio	-0.17
Sortino ratio (3Y)	0.75
Sortino ratio (5Y)	-0.43
Volume	120.2K
Weekly RSI	35.39
YTD price change	-46.58%
YTD total return	-46.58%

Metric

Value

10Y price change

-94.64%

10Y return CAGR

-25.37%

10Y total return

-94.64%

150-day SMA

$2.63

1D price change

1.04%

1M price change

-14.25%

1M total return

-14.25%

1W price change

0.77%

1W total return

0.77%

1Y price change

-23.93%

1Y return CAGR

-23.94%

1Y total return

-23.93%

20-day SMA

$1.98

200-day SMA

$2.80

3M price change

-40.21%

3M total return

-40.21%

3Y price change

9.83%

3Y return CAGR

3.17%

3Y total return

9.83%

50-day SMA

$2.34

50-day SMA vs 200-day SMA

50under200

52-week high

$4.53

52-week high date

2026-01-09

52-week low

$1.83

52-week low date

2026-10-19

5Y price change

-95.99%

5Y return CAGR

-47.45%

5Y total return

-95.99%

6M price change

-13.88%

6M total return

-13.88%

All-time high

$190.50

All-time high date

2013-04-23

All-time low

$1.24

All-time low date

2023-11-10

Average true range (ATR)

$0.09

Average volume

244.7K

Beta (1Y)

0.53

Beta (2Y)

0.71

Beta (5Y)

1.25

Change from 52-week high

-56.95%

Change from 52-week low

6.56%

Change from all-time high

-98.97%

Change from all-time low

57.66%

Change from open

0.52%

Day's gap

0.52%

Dollar volume

$234,367

High price

$1.97

Low price

$1.94

Monthly RSI

39.29

Open price

$1.94

Position in 52-week range

42.86%

Premarket change

0.52%

Premarket close

$1.93

Premarket price

$1.94

Premarket volume

113

Previous close

$1.93

Price vs 150-day SMA

-25.64%

Price vs 20-day SMA

-1.41%

Price vs 200-day SMA

-30.28%

Price vs 50-day SMA

-16.49%

Relative volume

0.49

RSI

39.59

Sharpe ratio

-0.18

Sharpe ratio (3Y)

0.44

Sharpe ratio (5Y)

-0.34

Sortino ratio

-0.17

Sortino ratio (3Y)

0.75

Sortino ratio (5Y)

-0.43

Volume

120.2K

Weekly RSI

35.39

YTD price change

-46.58%

YTD total return

-46.58%

Metric	Value
Float	21.4M
Float percentage	64.29%
Shares change (QoQ)	-17.24%
Shares change (YoY)	25.98%
Shares held by insiders	22.17%
Shares held by institutions	17.51%
Shares outstanding	33.4M
Short % of float	22.84%
Short % of shares	14.69%
Short ratio	17.9 days

Metric

Value

Float

21.4M

Float percentage

64.29%

Shares change (QoQ)

-17.24%

Shares change (YoY)

25.98%

Shares held by insiders

22.17%

Shares held by institutions

17.51%

Shares outstanding

33.4M

Short % of float

22.84%

Short % of shares

14.69%

Short ratio

17.9 days

Fortress Biotech, Inc. (FBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · FBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FBIO

Frequently asked questions